Skip to main content

Table 2 The results of CAG in the study patients

From: Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease

 

MS (MVR) (n=72)

MR (MVR) (n=93)

AS (AVR) (n=40)

AR (AVR) (n=36)

P value

Presence of CAD*

19 (26.4%)

39 (42%)

23 (57.5%)

16 (44.4%)

0.01

Gensini score**

2.97±8.75

11.02±25.26

11.20±28.26

7.55±16.98

0.077

CABG (%)

6 (8.3%)

12 (12.9%)

10 (25%)

6 (16.7%)

0.102

LVEF (%)

54.93±7.45

50.29±12.05

53.12±10.30

50.25±13.07

0.03

  1. CAG, Coronary artery angiography; MS, mitral stenosis; MR, mitral regurgitation; MVR, mitral valve replacement; AS, aortic stenosis; AR, aortic regurgitation; AVR, aortic valve replacement. CAD, Coronary artery disease; CABG, Coronary artery bypass graft; LVEF, Left ventricular ejection fraction.
  2. *The prevalence of CAD was significantly higher in AS group compared to MS group (p=0.002). The prevalence of CAD was significantly higher in MR group compared to MS group (p=0.02).
  3. **The Gensini score was significantly higher in MR group compared to MS group (p=0.005).
Back to article page

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us